Japan's Otsuka Pharma has agreed to take control of US biotech Jnana Therapeutics in a deal that will give it rights to a clinical-stage candidate for the rare metabolic disorder phenylketonuria (PKU) ...
From Deng Xiaoping to Xi Jinping, generations of Communist Party bosses and military leaders invested in a strategic but ...
Your home is trapping invisible pollutants. Each room could harbor distinct chemical threats from cooking fumes to aging ...
CHENGDU, China, Dec. 31, 2025 /PRNewswire/ — On December 27, the 2025 Master of Engineering Management (MEM) Industry Mentor ...
China has made a key breakthrough in the evolution of its central bank's digital currency by positioning the e-CNY as ...
It is also a guarantee of our shared future as it complements the national education system rather than competing with it.
Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.
BioMarin Pharma has had another setback in its gene therapy development programme, announcing this morning that the FDA has placed a phase 1/2 trial of its candidate for phenylketonuria (PKU) on hold ...
Moscow’s ambassador tells Beijing forum that relations between the two countries have reached their ‘highest level in history ...
China relations are maintaining strong and comprehensive momentum and have reached an “unprecedented height” while entering a ...
China has imposed steep tariffs on EU dairy products, escalating trade tensions with Brussels as disputes widen over EVs, ...